Molbio Diagnostics
Demand
Red-hot
subscribed 70.27x overall
Listed
+21.4%
day-1 close +28.4% vs issue
Final Subscription
Subscribed 70.27xoverall · last updated 2026-08-26 00:45 UTC
| Category | Shares reserved | 23-08 | 24-08 | 26-08 | |||
|---|---|---|---|---|---|---|---|
| Shares bid | Times | Shares bid | Times | Shares bid | Times | ||
| ∟QIB (Ex Anchor) | 23,25,146 | 43,33,82,148 | 186.39× | 43,33,82,148 | 186.39× | 43,33,82,148 | 186.39× |
| NII | 17,43,859 | 8,68,40,604 | 49.80× | 8,68,40,604 | 49.80× | 8,68,40,604 | 49.80× |
| ∟bNII (> ₹10L) | 11,62,573 | 5,90,76,594 | 50.82× | 5,90,76,594 | 50.82× | 5,90,76,594 | 50.82× |
| ∟sNII (< ₹10L) | 5,81,286 | 2,77,64,010 | 47.76× | 2,77,64,010 | 47.76× | 2,77,64,010 | 47.76× |
| Retail | 40,69,004 | 5,27,70,906 | 12.97× | 5,27,70,906 | 12.97× | 5,27,70,906 | 12.97× |
| Employee | 20,520 | 2,72,466 | 13.28× | 2,72,466 | 13.28× | 2,72,466 | 13.28× |
| Total | 81,58,529 | 57,32,66,124 | 70.27× | 57,32,66,124 | 70.27× | 57,32,66,124 | 70.27× |
Allotment odds (1 lot lottery once oversubscribed) — Retail: ≈ 1 in 13 applicants · Small NII: ≈ 1 in 48 applicants · Big NII: ≈ 1 in 51 applicants
Allotment Probability
Retail · subscribed 12.97x
8%
Small HNI (sNII) · subscribed 47.76x
2%
Big HNI (bNII) · subscribed 50.82x
2%
Chance of winning at least one lot per application, from the shares reserved for the category vs current demand. QIB allots pro-rata, not by lottery. Demand can spike on the final day.
📋Issue Details
| Offer Type | Bookbuilding IPO |
| Sale Type | Fresh capital cum OFS |
| Listing At | BSE, NSE |
| Face Value | ₹ 1 per share |
| Price Band | ₹768 to ₹807 |
| Lot Size | 18 shares |
| Total Issue Size | 1,16,46,246 shares (agg. up to ₹ 940 Cr) |
| Fresh Issue | 24,80,246 shares (agg. up to ₹ 200 Cr) |
| Offer for Sale | 91,66,000 shares of ₹ 1 (agg. up to ₹ 740 Cr) |
| Scrip / Symbol | 544866 / MOLBIO |
| ISIN | INE869T01028 |
🗓️IPO Schedule
Open
Mon, Aug 10, 2026
Close
Wed, Aug 12, 2026
Allotment
Thu, Aug 13, 2026
Refunds
Fri, Aug 14, 2026
Demat credit
Fri, Aug 14, 2026
Listing
Mon, Aug 17, 2026
🏛️Pre & Post Issue Capital
| Category | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 44.89% | 41.29% |
| Public | 55.11% | 58.71% |
| Total | 100% | 100% |
💰Valuation & Market Cap
| EPS(₹) (pre → post) | 14.56 → 14.24 |
| P/E (x) (pre → post) | 55.43 → 56.67 |
| Market Cap at Offer Price | ₹12,004.55 Cr |
📊Company Financials ₹ crore
| Metric | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 2,148.42 | 1,461.56 | 1,221.06 |
| Total Income | 1,455.17 | 1,027.94 | 840.66 |
| Profit After Tax | 164.14 | 138.58 | 83.54 |
| EBITDA | 328.24 | 256.64 | 185.09 |
| NET Worth | 1,144.68 | 952.95 | 807.94 |
| Reserves and Surplus | 1,148.84 | 990.84 | 845.48 |
| Total Borrowing | 412.64 | 123.16 | 174.58 |
🎯Key Performance Indicators
| ROE | 15.59% |
| ROCE | 17.55% |
| RoNW | 14.55% |
| PAT Margin | 11.28% |
| EBITDA Margin | 22.56% |
| NAV | 101.51 |
| Price to Book Value |
🤝Recently Listed PeersMedical Equipment & Supplies
| Company | Issue price | P/E | Listing-day close |
|---|---|---|---|
| Fabtech Technologies Ltd. | ₹191 | 13.32 | ₹182.40 |
| Q-Line Biotech Ltd. | ₹343 | 20.82 | ₹474.60 |
| Earkart Ltd. | ₹135 | 20.48 | ₹142.25 |
| Galaxy Medicare Ltd. | ₹54 | 19.01 | ₹51.30 |
Lot Size — what an application costs
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 18 | ₹14,526 |
| Retail (Max) | 13 | 234 | ₹1,88,838 |
| S-HNI (Min) | 14 | 252 | ₹2,03,364 |
| S-HNI (Max) | 68 | 1,224 | ₹9,87,768 |
| B-HNI (Min) | 69 | 1,242 | ₹10,02,294 |
Issue Reservation
| Category | Shares | % of issue | Max allottees |
|---|---|---|---|
| QIB | 58,12,862 | 50.00% | 49.91% |
| − Anchor Investor | 34,87,717 | 29.95% | |
| − QIB (Ex. Anchor) | 23,25,145 | 19.96% | |
| NII (HNI) | 17,43,860 | 15.00% | 14.97% |
| − bNII > ₹10L | 11,62,573 | 9.98% | |
| − sNII < ₹10L | 5,81,287 | 4.99% | |
| Retail | 40,69,005 | 35.00% | 34.94% |
| Employee | 20,519 | 0.18% | |
| Total | 1,16,46,246 | 100.00% | 100.00% |
🔔Listing Day
Issue price
₹807
Listing open
₹980
Open vs issue
+21.4%
Day-1 close
+28.4%
vs issue price
🏢About Molbio Diagnostics
Molbio Diagnostics IPO is a book build issue of ₹939.70 crores. The issue is a combination of fresh issue of 0.25 crore shares aggregating to ₹200.12 crores and offer for sale of 0.92 crore shares aggregating to ₹739.57 crores.
Molbio Diagnostics IPO bidding started from Aug 10, 2026 and ended on Aug 12, 2026. The allotment for Molbio Diagnostics IPO was finalized on Aug 13, 2026. The shares got listed on NSE and BSE on Aug 17, 2026.
Molbio Diagnostics IPO is set final issue price at ₹807 per share. The lot size for an application is 18 shares. The minimum amount of investment required by an individual investor (retail) is ₹14,526 (18 shares) (based on upper price).
The issue includes a reservation of up to 20,519 shares for employees offered at a discount of ₹76.00 to the issue price.
🎯Objects of the Issue
| Object | ₹ Cr |
|---|---|
| Funding capital expenditure towards the setting up of infrastructure for research and deve | 105.54 |
| Funding capital expenditure towards the purchase of certain plant, machinery and other equ | 72.28 |
| General Corporate Purposes | 9.47 |
| Issue Expenses | 59.54 |
👥Selling Shareholders
| Name | Category | Shares offered |
|---|---|---|
| Exxora Trading LLP | Promoter | 18,11,000 |
| India Business Excellence Fund III | Corporate | 10,00,000 |
| Chandrasekhar Bhaskaran Nair | Promoter | 12,21,000 |
| Gopalkrishna Mangalore Kini | Other | 11,25,000 |
| J.Guru Dutt | Other | 9,02,000 |
| Gopalakrishna Sampathgiri | Other | 9,02,000 |
| Sangeetha M.Kini | Other | 4,52,000 |
| M.A.Usha Rani | Other | 4,51,000 |
| M.A.Rohit | Other | 2,48,000 |
| Abdul Qadir Mohamed Theruvath | Other | 48,000 |
| Chewbacca Services Ltd. | Corporate | 1,93,000 |
| M.Ganesh Kamath | Other | 17,000 |
| M.A.Sharath | Other | 2,02,000 |
| Shaheeda Abdul Kader | Other | 97,000 |
| Shruthi G.Kini | Other | 2,26,000 |
| Sujay Ltd. | Corporate | 1,93,000 |
| Vivek Devaraj | Other | 78,000 |
| Total | 91,66,000 |
💼Lead Managers
- • Kotak Mahindra Capital Co.Ltd.
- • IIFL Capital Services Ltd.
- • Jefferies India Pvt.Ltd.
- • Motilal Oswal Investment Advisors Ltd.
🗳️Registrar
- • Kfin Technologies Ltd.
- allotment status is checked on the registrar's portal
🏢Registered Office
📍 Plot No. L-46, Phase II-D, Verna Industrial Area, Verna, Salcete, South Goa, Goa, 403722
📞 8326724888
✉️ investors@molbiodiagnostics.com
Grey-market numbers are unofficial street quotes, aggregated across sources. Not investment advice.